Vasomune is developing a novel first-in-class investigational medicine to treat patients hospitalized with severe COVID-19 disease. The phase 1 study is the first-in-human study designed to demonstra...
VASOMUNE THERAPEUTICS INC.
3 records totalling $3,067,893.00 CAD, from official Government of Canada open data.
Embed this chart
Lobbying registry — possible match matched by name
An organization with this name appears in 6 federal lobbying registrations (0 currently active), between 2020 and 2020.
777373-366590-2 — StrategyCorp Inc. 892138-366598-2 — StrategyCorp Inc 932634-366599-2 — StrategyCorp Inc.
Matched automatically by organization name; a different organization with the same name is possible. The Registry of Lobbyists is the authoritative source. Lobbying is legal and regulated — this is context, not an allegation.
By department
| National Research Council Canada | $3,067,893 | 3 records |
Records
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.